reference/22079885

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22079885

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	31
issn	0098-7484
issueIdentifier	12
pageRange	1319-31
publicationName	JAMA
startingPage	1319
bibliographicCitation	Konstam MA, Gheorghiade M, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007 Mar 28;297(12):1319–31. doi: 10.1001/jama.297.12.1319. PMID: 17384437.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87699aab88b796d8f8077f77ec71c96c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a49dca3de5abe2e460b3725418211fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d3925b23a088bef5d7a5d5e64981fed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_377aa5f78e7f189e8514fce90d928f53 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f328e14c26db8787e887c66d1ae9618 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf50e273be8fe9c1b42e8ec98b8dd115 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_468cecca75adc236c1d67cbceac0b8c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da1f85500a8c9dc09829711f57a7a720 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9bb8abeb07990e47ae40c2c9665059e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2ac075b646b6615ce804679dab2f3b9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2d32894eb8f0b14b3f5f242ae064c19 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32d0c43c212fde43b2dae8bf448abeb0
date	2007-03-28^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1001/jama.297.12.1319 https://pubmed.ncbi.nlm.nih.gov/17384437
isPartOf	https://portal.issn.org/resource/ISSN/0098-7484 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5346
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart FailureThe EVEREST Outcome Trial
discusses	http://id.nlm.nih.gov/mesh/M0299851 http://id.nlm.nih.gov/mesh/M0005300 http://id.nlm.nih.gov/mesh/M0020091 http://id.nlm.nih.gov/mesh/M0002330 http://id.nlm.nih.gov/mesh/M0587243 http://id.nlm.nih.gov/mesh/M0003472
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006333Q000188 http://id.nlm.nih.gov/mesh/D001552Q000627 http://id.nlm.nih.gov/mesh/D065092 http://id.nlm.nih.gov/mesh/D002317Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006333Q000097 http://id.nlm.nih.gov/mesh/D006333Q000401 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D006760 http://id.nlm.nih.gov/mesh/D001806 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D003404Q000097 http://id.nlm.nih.gov/mesh/D011788 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D012964Q000097 http://id.nlm.nih.gov/mesh/D000077602 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001835Q000187
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9653 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7922 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216237 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8563 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7521 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7548 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8126

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128023819 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127788218

Showing number of triples: 1 to 67 of 67.